{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:56:30Z","timestamp":1787237790448,"version":"build-2736575974"},"reference-count":42,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,14]]},"DOI":"10.5334\/gh.1211","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T06:45:48Z","timestamp":1686725148000},"source":"Crossref","is-referenced-by-count":6,"title":["Prevalence, Predictors, and Outcomes of Resistant Hypertension in Egyptian Population"],"prefix":"10.5334","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6105-9300","authenticated-orcid":false,"given":"Mohamed","family":"Khalfallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-2034","authenticated-orcid":false,"given":"Ayman","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-9495","authenticated-orcid":false,"given":"Ahmad","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5569-5781","authenticated-orcid":false,"given":"Basma","family":"Elnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"issue":"2","key":"key20230614064544_B1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990\u20132015","volume":"317","year":"2017","journal-title":"JAMA"},{"key":"key20230614064544_B2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"The Lancet"},{"key":"key20230614064544_B3","first-page":"1","article-title":"Hypertension prevalence among adults aged 18 and over: United States, 2017\u20132018","volume":"364","year":"2020","journal-title":"NCHS Data Brief"},{"key":"key20230614064544_B4","article-title":"Trends in healthcare expenditures among US adults with hypertension: National estimates, 2003\u20132014","volume":"7","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"key20230614064544_B5","author":"World Health Organization RoftEM","year":"2017"},{"issue":"7","key":"key20230614064544_B6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41371-019-0265-0","article-title":"Registry of the Egyptian specialized hypertension clinics: Patient risk profiles and geographical differences","volume":"34","year":"2020","journal-title":"J Hum Hypertens"},{"issue":"5","key":"key20230614064544_B7","first-page":"e53","article-title":"Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association","volume":"72","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"key20230614064544_B8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.118.12191","article-title":"Prevalence of apparent treatment-resistant hypertension in the United States","volume":"73","year":"2019","journal-title":"Hypertension"},{"issue":"7","key":"key20230614064544_B9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11906-017-0754-x","article-title":"Resistant hypertension: Mechanisms and treatment","volume":"19","year":"2017","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"key20230614064544_B10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjcard.2012.03.035","article-title":"Relation of systemic blood pressure to sudden cardiac death","volume":"110","year":"2012","journal-title":"Am J Cardiol"},{"issue":"20","key":"key20230614064544_B11","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"key20230614064544_B12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/heartjnl-2018-313599","article-title":"Global prevalence of resistant hypertension: A meta-analysis of data from 3.2 million patients","volume":"105","year":"2019","journal-title":"Heart"},{"key":"key20230614064544_B13","year":"2011"},{"issue":"4","key":"key20230614064544_B14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ihj.2017.01.012","article-title":"Prevalence and characteristics of resistant hypertensive patients in an Asian population","volume":"69","year":"2017","journal-title":"Indian Heart J"},{"key":"key20230614064544_B15","first-page":"1440","article-title":"Recommendations for chamber quantification: A report from the American Society of echocardiography\u2019s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"key20230614064544_B16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.17219\/acem\/58998","article-title":"Resistant Hypertension","volume":"25","year":"2016","journal-title":"Adv Clin Exp Med"},{"issue":"9","key":"key20230614064544_B17","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.18203\/2349-3933.ijam20213252","article-title":"Resistant hypertension: A review","volume":"8","year":"2021","journal-title":"International Journal of Advances in Medicine"},{"key":"key20230614064544_B18","first-page":"j3984","article-title":"Trends for prevalence and incidence of resistant hypertension: Population based cohort study in the UK 1995\u20132015","volume":"358","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"key20230614064544_B19","first-page":"270","article-title":"Resistant hypertension: Demography and clinical characteristics in 6,292 patients in a primary health care setting","volume":"67","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"2","key":"key20230614064544_B20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1590\/2175-8239-jbn-2018-0108","article-title":"Resistant and refractory hypertension: Two sides of the same disease?","volume":"41","year":"2019","journal-title":"J Bras Nefrol"},{"issue":"9","key":"key20230614064544_B21","article-title":"The highly neglected burden of resistant hypertension in Africa: A systematic review and meta-analysis","volume":"6","year":"2016","journal-title":"BMJ Open"},{"key":"key20230614064544_B22","first-page":"424","article-title":"An observational study of hypertension treatment and patient outcomes in a primary care setting","volume":"20","year":"2015","journal-title":"Pan Afr Med J"},{"key":"key20230614064544_B23","article-title":"PP. 40.21: Prevalence and causes of resistant hypertension in specialized consultation in the area of blida (Algeria)","volume":"33","year":"2015","journal-title":"Journal of Hypertension"},{"issue":"4","key":"key20230614064544_B24","article-title":"Treatment resistant hypertension among ambulatory hypertensive patients: A cross sectional study","volume":"15","year":"2020","journal-title":"PLoS One"},{"issue":"05","key":"key20230614064544_B25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4236\/wjcd.2020.105026","article-title":"True resistant hypertension among treated hypertensive black patients. A clinical-based cross-sectional study","volume":"10","year":"2020","journal-title":"World J Cardiovasc Dis"},{"key":"key20230614064544_B26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2296-15-131","article-title":"Prevalence and predictors of resistant hypertension in a primary care setting: A cross-sectional study","volume":"15","year":"2014","journal-title":"BMC Fam Pract"},{"issue":"5","key":"key20230614064544_B27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semnephrol.2014.08.001","article-title":"Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population","volume":"34","year":"2014","journal-title":"Semin Nephrol"},{"issue":"1","key":"key20230614064544_B28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/HYPERTENSIONAHA.120.15064","article-title":"Adverse health outcomes associated with refractory and treatment-resistant hypertension in the chronic renal insufficiency cohort","volume":"77","year":"2021","journal-title":"Hypertension"},{"issue":"5","key":"key20230614064544_B29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cjca.2022.01.029","article-title":"Epidemiology of resistant hypertension in Canada","volume":"38","year":"2022","journal-title":"Can J Cardiol"},{"issue":"6","key":"key20230614064544_B30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.ki.5000177","article-title":"Hypertension in renal parenchymal disease: Why is it so resistant to treatment?","volume":"69","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"key20230614064544_B31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.amjmed.2013.07.038","article-title":"Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease","volume":"127","year":"2014","journal-title":"Am J Med"},{"issue":"9","key":"key20230614064544_B32","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008","volume":"124","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"key20230614064544_B33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/pharma1010003","article-title":"Risk of obstructive sleep apnea in adults with resistant hypertension","volume":"1","year":"2022","journal-title":"Pharmacoepidemiology"},{"issue":"4","key":"key20230614064544_B34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2869.2010.00839.x","article-title":"Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension","volume":"19","year":"2010","journal-title":"J Sleep Res"},{"issue":"8","key":"key20230614064544_B35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/hr.2015.39","article-title":"Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study","volume":"38","year":"2015","journal-title":"Hypertens Res"},{"issue":"2","key":"key20230614064544_B36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00325481.2017.1272398","article-title":"Prevalence, clinical characteristics and echocardiography parameters of non-resistant, resistant and refractory hypertension in Chinese","volume":"129","year":"2017","journal-title":"Postgrad Med"},{"issue":"12","key":"key20230614064544_B37","article-title":"The prevalence and prognosis of resistant hypertension in patients with heart failure","volume":"9","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"key20230614064544_B38","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/jch.14043","article-title":"Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients","volume":"22","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"13","key":"key20230614064544_B39","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"key20230614064544_B40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"4","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"key20230614064544_B41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.115.06487","article-title":"Prevalence and prognostic significance of apparent treatment resistant hypertension in chronic kidney disease: Report from the chronic renal insufficiency cohort study","volume":"67","year":"2016","journal-title":"Hypertension"},{"key":"key20230614064544_B42","first-page":"236239","article-title":"Common secondary causes of resistant hypertension and rational for treatment","volume":"2011","year":"2011","journal-title":"Int J Hypertens"}],"container-title":["Global Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-gh-files\/journals\/1\/articles\/1211\/648998dc060d7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:56:51Z","timestamp":1761551811000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/articles\/10.5334\/gh.1211\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,6,14]]}},"alternative-id":["10.5334\/gh.1211"],"URL":"https:\/\/doi.org\/10.5334\/gh.1211","relation":{},"ISSN":["2211-8179"],"issn-type":[{"value":"2211-8179","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"31"}}